Advertisement

Covidien plc has won approval in both the U.S. and Europe to market its Parietex Optimized Composite (PCOx) mesh used in surgical hernia repair, the company said today.

With the U.S. Food and Drug Administration granting 510(k) clearance and European regulators granting CE Mark approval, Coviden plans to begin selling the mesh this month.

SOURCE

Advertisement
Advertisement